Finance

Beta
Lists
ABDX:LON
Abingdon Health PLC
GBX 11.29
-11.44%
(-1.46) 1D
Jun 5, 5:35:05 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for ABDX...
Open
GBX 12.80
High
GBX 13.00
Low
GBX 11.29
Mkt. cap
28.54M
Avg. vol.
542.61K
Volume
274.67K
52-wk high
GBX 13.00
52-wk low
GBX 5.10
EPS
-GBX 0.01
Shares outstanding
252.75M
No. of employees
129
Open
GBX 12.80
High
GBX 13.00
Low
GBX 11.29
Mkt. cap
28.54M
Avg. vol.
542.61K
Volume
274.67K
52-wk high
GBX 13.00
52-wk low
GBX 5.10
EPS
-GBX 0.01
Shares outstanding
252.75M
No. of employees
129
News stories
From sources across the web
Profile
Abingdon Health is a leading international developer, manufacturer and distributor of lateral flow assay diagnostic tests, sometimes called rapid tests, lateral flow immunoassays, lateral flow tests or quick tests. Since its formation in 2008, Abingdon Health has developed and manufactured lateral flow rapid tests across multiple industries. Headquartered in York, with sites in Doncaster and Madison, USA. Wikipedia
About Abingdon Health PLC
CEOChris Yates
Employees129
FoundedJan 1, 2008
Headquarters-
SectorMedical device
Websiteabingdonhealth.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.67M
2.67M
2.12M
2.12M
Cost of goods sold
1.39M
1.39M
1.41M
1.41M
Cost of revenue
1.39M
1.39M
1.41M
1.41M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.25M
2.25M
2.06M
2.06M
Operating expense
2.33M
2.33M
1.85M
1.85M
Total operating expenses
3.72M
3.72M
3.26M
3.26M
Operating income
-1.05M
-1.05M
-1.14M
-1.14M
Other non operating income
221.00K
221.00K
-
-
EBT including unusual items
-431.50K
-431.50K
-1.15M
-1.15M
EBT excluding unusual items
-819.00K
-819.00K
-1.15M
-1.15M
Income tax expense
15.50K
15.50K
25.50K
25.50K
Effective tax rate
-3.59%
-3.59%
-2.22%
-2.22%
Other operating expenses
-170.50K
-170.50K
-211.50K
-211.50K
Net income
-447.00K
-447.00K
-1.17M
-1.17M
Net profit margin
-16.76%
-16.76%
-55.44%
-55.44%
Earnings per share
-
-
-
-
Interest and investment income
26.00K
26.00K
8.00K
8.00K
Interest expense
-16.00K
-16.00K
-15.50K
-15.50K
Net interest expenses
10.00K
10.00K
-7.50K
-7.50K
Depreciation and amortization charges
141.00K
141.00K
-
-
EBITDA
-951.00K
-951.00K
-964.00K
-964.00K
Gain or loss from assets sale
15.00K
15.00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer